JP2012236834A5 - - Google Patents

Download PDF

Info

Publication number
JP2012236834A5
JP2012236834A5 JP2012156634A JP2012156634A JP2012236834A5 JP 2012236834 A5 JP2012236834 A5 JP 2012236834A5 JP 2012156634 A JP2012156634 A JP 2012156634A JP 2012156634 A JP2012156634 A JP 2012156634A JP 2012236834 A5 JP2012236834 A5 JP 2012236834A5
Authority
JP
Japan
Prior art keywords
pin
use according
precancerous lesion
total catechin
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012156634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012236834A (ja
Filing date
Publication date
Priority claimed from ITBZ20040037 external-priority patent/ITBZ20040037A1/it
Priority claimed from ITBZ20050004 external-priority patent/ITBZ20050004A1/it
Application filed filed Critical
Publication of JP2012236834A publication Critical patent/JP2012236834A/ja
Publication of JP2012236834A5 publication Critical patent/JP2012236834A5/ja
Pending legal-status Critical Current

Links

JP2012156634A 2004-07-27 2012-07-12 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物 Pending JP2012236834A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITBZ2004A000037 2004-07-27
ITBZ20040037 ITBZ20040037A1 (it) 2004-07-27 2004-07-27 Miscela di catechine ovvero polifenoli estratti dal te' verde cinese o da altri vegetali con efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico.
ITBZ20050004 ITBZ20050004A1 (it) 2005-02-16 2005-02-16 Miscela di catechine ovvero polifenoli estratti dal Te' Verde cinese (o da altri vegetali) Efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico e per il trattamento efficace della sintomatologia dell'ipertrofia prostati
ITBZ2005A000004 2005-02-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007523166A Division JP2008508252A (ja) 2004-07-27 2005-07-21 前立腺癌発病予防および前立腺肥大（ｂｐｈ）の総合的症状の効果的な治療のための、化学的な予防効果を有する、中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物

Publications (2)

Publication Number Publication Date
JP2012236834A JP2012236834A (ja) 2012-12-06
JP2012236834A5 true JP2012236834A5 (enExample) 2013-01-24

Family

ID=35447932

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007523166A Pending JP2008508252A (ja) 2004-07-27 2005-07-21 前立腺癌発病予防および前立腺肥大（ｂｐｈ）の総合的症状の効果的な治療のための、化学的な予防効果を有する、中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物
JP2012156634A Pending JP2012236834A (ja) 2004-07-27 2012-07-12 前立腺癌の予防および前立腺肥大（ｂｐｈ）の処置のための中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007523166A Pending JP2008508252A (ja) 2004-07-27 2005-07-21 前立腺癌発病予防および前立腺肥大（ｂｐｈ）の総合的症状の効果的な治療のための、化学的な予防効果を有する、中国緑茶またはその他の野菜から抽出したカテキン、さらに正確にはポリフェノールの混合物

Country Status (7)

Country Link
US (1) US8044095B2 (enExample)
EP (1) EP1781375B1 (enExample)
JP (2) JP2008508252A (enExample)
CA (1) CA2612149C (enExample)
ES (1) ES2427170T3 (enExample)
PL (1) PL1781375T3 (enExample)
WO (1) WO2006013420A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053857A2 (en) * 2007-10-26 2009-04-30 Csir Management and treatment of benign prostatic hyperplasia
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
AU2009306592B2 (en) * 2008-10-20 2013-05-23 Unilever Global Ip Limited An antimicrobial composition
CA2801143C (en) 2009-09-24 2017-09-26 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
MX2013006435A (es) 2010-12-07 2013-07-03 Unilever Nv Composicion para cuidado oral.
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
EP2782550A2 (en) * 2011-11-25 2014-10-01 Unilever N.V. An oral care composition comprising polyphenol
WO2013081046A1 (ja) * 2011-11-29 2013-06-06 国立大学法人信州大学 ブドウ梗由来抽出物
CN102754832A (zh) * 2012-07-12 2012-10-31 赵四海 用酚和醌融解肿瘤和改造癌细胞的治病方法
WO2014062677A1 (en) * 2012-10-15 2014-04-24 Kemin Industries, Inc. A blend of green and black extracts for the promotion of health benefits
KR101492713B1 (ko) * 2013-05-06 2015-02-12 대구한의대학교산학협력단 미숙 떫은 감의 분획물을 이용한 전립선 비대증 예방 또는 치료용 조성물
US11839639B2 (en) 2017-10-19 2023-12-12 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266977A (en) * 1991-07-12 1993-11-30 Linden Harry A Lens device and method
US5585871A (en) * 1995-05-26 1996-12-17 Linden; Harry Multi-function display apparatus
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
DE19842858A1 (de) 1998-09-18 2000-03-30 Vollbrecht H Ruediger Entkoffeinierung von Tee
KR100319973B1 (ko) 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6431705B1 (en) * 1999-11-10 2002-08-13 Infoeye Eyewear heart rate monitor
WO2002067966A1 (en) * 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
WO2002067965A1 (en) 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer

Similar Documents

Publication Publication Date Title
JP2012236834A5 (enExample)
WO2012079092A3 (en) Testosterone undecanoate compositions
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
JP2010270124A5 (enExample)
JP2012255026A5 (enExample)
HRP20192133T1 (hr) Kemijski spoj koristan kao posrednik za pripremu inhibitora katekol-o-metiltransferaze
AR069312A1 (es) Composicion farmaceutica que comprende beta oxihidroxido de hierro en alta carga en forma adecuada para administarcion oral y que contiene al menos un hidrato de carbono y/o acido humico y su uso en el tratamiento de pacientes con hiperfosfatemia y con insuficiencia renal cronica , y procedimento pa
WO2013183062A3 (en) Palatable formulations of ibuprofen
JP2015038135A5 (enExample)
EA201290734A1 (ru) Рифаксимин в форме порошка, способ его получения и композиции контролируемого высвобождения, содержащие указанный рифаксимин, полезные для достижения длительного эффекта
JP2013516493A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2016501862A5 (enExample)
RU2014129508A (ru) Новая комбинация
ME02474B (me) Terapijski režimi
JP2019530706A5 (enExample)
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
JP2011513340A5 (enExample)
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
JP2012041314A5 (enExample)
RU2014141615A (ru) Новое противоопухолевое средство, включающее комбинацию трех агентов
JP2008533023A5 (enExample)
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
WO2011108882A3 (ko) 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물